6月18日汇添富医疗积极成长一年持有混合A净值增长0.63%，今年来累计上涨35.18%

Group 1 - The core viewpoint of the news is the performance and holdings of the Huatai-PineBridge Medical Active Growth One-Year Holding Mixed Fund A, which has shown significant returns in various time frames [1] - As of June 18, 2025, the fund's latest net value is 0.6747 yuan, reflecting a growth of 0.63% [1] - The fund's performance over the past month has yielded a return of 16.12%, ranking 61 out of 4668 in its category [1] - Over the past six months, the fund has achieved a return of 31.70%, ranking 103 out of 4512 [1] - Year-to-date, the fund has returned 35.18%, ranking 89 out of 4534 [1] Group 2 - The top ten stock holdings of the fund account for a total of 56.30%, with the largest holding being Kelun-Botai at 9.63% [1] - Other significant holdings include BeiGene-U (8.84%), Kangfang Biotech (7.07%), and Betta Pharmaceuticals (5.98%) [1] - The fund was established on August 21, 2020, and as of March 31, 2025, it has a total scale of 1.68 billion yuan [1] Group 3 - The fund manager, Zheng Lei, has a background in social medicine and health management from Fudan University and has held various positions in the finance and investment sectors [2] - Zheng Lei has been with Huatai-PineBridge since November 2017 and has managed multiple funds, including the Huatai-PineBridge Medical Active Growth One-Year Holding Mixed Fund since its inception [2]